Costco's $14.99 Insulated Lunch Box Bundle Is a Must-Have Deal for Back-to-School and Beyond
Although summer may have just begun, it's never too early to think about back-to-school prep. Let's be real. Once the Fourth of July hits, we blink, and it's Christmas. So, getting a head start, especially with a smart, budget-friendly deal, just makes sense.
That's why the Titan Arctic Zone Fridge Cold, Crush-Resistant Lunch Pack at Costco is turning heads. This rugged, roomy lunch box is perfect for keeping lunches fresh, whether you're packing for school, work, or your next road trip.
Take a look!
This is such a value, and it's why we love Costco! As @costcotwins showed us, this cooler pack is equipped with high-performance features that make it a standout. It has two 250g High-Performance Ice Walls® that tuck into outer zippered pockets to maximize interior space. A four-piece leakproof food container set. And insulation with a radiant barrier to keep contents fridge cold for up to 6 hours or chilled for up to 12 hours.
Related: Sleek New Costco Air Fryer Is PFAS-Free, Portable, and Built for Speed
Additionally, it features a leakproof lining with antimicrobial protection, a crush-resistant and water-repellent exterior, and dual-padded handles. Plus, it has a removable and adjustable shoulder strap for easy carrying. What more could we ask for?
With a durable design and easy-clean lining, this lunch pack is just as great for adults trying to save money and eat healthier as it is for kids heading back to school. For $14.99 in-store or a 2-pack online for $39.99, it's an everyday essential that makes busy routines a little easier and a lot cooler.
Just be sure to capture this Costco deal before it ends on July 20th!
Copyright 2025 The Arena Group, Inc. All Rights Reserved

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Wire
7 hours ago
- Business Wire
WST截止日期:Rosen Law Firm敦促損失超過10萬美元的West Pharmaceutical Services, Inc. (NYSE: WST)股東與法律事務所聯絡以瞭解有關其權利的資訊
紐約--(BUSINESS WIRE)--(美國商業資訊)-- 全球投資人權益法律事務所Rosen Law Firm提醒投資人,一名股東代表在2023年2月16日至2025年2月12日期間購買West Pharmaceutical Services, Inc. (NYSE: WST)證券的投資人提起了集體訴訟。West將自身描述為一家「專注於注射藥物包裝元件、密封解決方案及輸送系統的醫療用品公司」。 如欲瞭解更多資訊,請遞交 表格 、向Phillip Kim律師 寄送電子郵件 ,或致電866-767-3653聯絡我們。 指控內容:Rosen Law Firm正在調查對West Pharmaceutical Services, Inc. (NYSE: WST)在其業務營運方面誤導投資人的指控。 起訴書指稱,在整個集體訴訟期內,被告做出了虛假和誤導性陳述及/或未揭露:(1)儘管聲稱對客戶需求有清晰預判,並將業務阻力歸咎於COVID相關產品的臨時性去庫存,但West實際上在其高利潤率的高價值產品(HVP)組合中持續經歷著顯著的去庫存現象;(2) West的SmartDose裝置雖被標榜為高利潤率的成長型產品,但由於營運效率不彰,對West的利潤率造成了嚴重稀釋;(3)這些利潤率壓力引發了高昂重整活動的風險,包括West退出與長期客戶簽署的持續血糖監測(CGM)合約;以及(4)由於上述原因,被告關於West的業務、營運和前景的正面陳述具有重大誤導性和/或缺乏合理依據。訴訟稱,當市場瞭解真實詳情後,投資人蒙受了損失。 現在怎麼辦:您可能有資格參與針對West Pharmaceutical Services, Inc.的集體訴訟。如果有股東希望擔任該集體訴訟的原告代表,則必須在2025年7月7日之前向法院提出申請。原告代表是指代表其他集體訴訟成員主導訴訟的當事人代表。您無需參與此案即有資格獲得追償。如果您選擇不採取任何行動,您也可以保持缺席集體訴訟成員的身分。如欲瞭解更多資訊,請點選 此處 。 所有代理均為勝訴後取酬。股東無需支付任何費用或開支。 關於Rosen Law Firm:與Rosen Law Firm不同,一些就此等事宜發表公告的法律事務所並不會實際提起證券集體訴訟。身為股東權益訴訟領域公認的領導者, Rosen Law Firm 一直致力於協助股東挽回損失、改善公司治理結構,並追究公司高階主管的違法行為責任。自成立以來,Rosen Law Firm已經為股東挽回了超過10億美元的損失。 請在LinkedIn: 、Twitter: 或Facebook: 上關注我們,以瞭解最新情況。 律師廣告。先前案例不保證可獲致類似結果。 免責聲明:本公告之原文版本乃官方授權版本。譯文僅供方便瞭解之用,煩請參照原文,原文版本乃唯一具法律效力之版本。


Business Wire
7 hours ago
- Business Wire
ELV Deadline: Rosen Law Firm Urges Elevance Health, Inc. (NYSE: ELV) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. The Allegations: Rosen Law Firm is Investigating the Allegations that Elevance Health, Inc. (NYSE: ELV) Misled Investors Regarding its Business Operations. According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose that, with the Medicaid redetermination process nearly complete, defendants represented to investors that they were closely monitoring cost trends associated with the redetermination process and that the premium rates Elevance was negotiating with states were sufficient to address the risk and cost profiles of those patients staying on Medicaid programs. While defendants acknowledged that Medicaid expenses were rising, they repeatedly assured investors that this was adequately reflected in Elevance's guidance for the year. These representations were materially false or misleading. In truth, the redeterminations were causing the acuity and utilization of Elevance's Medicaid members to rise significantly, as the members being removed from Medicaid programs were, on average, healthier than those who remained eligible for the programs. This shift was occurring to a degree that was not reflected in Elevance's rate negotiations with the states or in its financial guidance for 2024. When the true details entered the market, the lawsuit claims that investors suffered damages. What Now: You may be eligible to participate in the class action against Elevance Health, Inc. Shareholders who want to serve as lead plaintiff for the class must file their motions with the court by July 11, 2025. A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here. All representation is on a contingency fee basis. Shareholders pay no fees or expenses. About Rosen Law Firm: Some law firms issuing releases about this matter do not actually litigate securities class actions. Rosen Law Firm does. Rosen Law Firm is a recognized leader in shareholder rights litigation, dedicated to helping shareholders recover losses, improving corporate governance structures, and holding company executives accountable for their wrongdoing. Since its inception, Rosen Law Firm has obtained over $1 billion for shareholders. Follow us for updates on LinkedIn: on Twitter: or on Facebook: Attorney Advertising. Prior results do not guarantee a similar outcome.
Yahoo
10 hours ago
- Yahoo
Affirm, Shopmonkey Partner to Revolutionize Auto Repair Payments
Affirm Holdings Inc. (NASDAQ:AFRM) is one of the best software infrastructure stocks to invest in. On June 25, Affirm Holdings announced a partnership with Shopmonkey that makes Affirm a default pay-over-time option for thousands of auto shops using Shopmonkey's payment processing solution in both the US and Canada. This allows customers to split their auto repair bills into flexible biweekly or monthly payment plans, with interest rates as low as 0% APR, and notably, no late or hidden fees. The initiative aims to empower small to medium-sized auto shops by providing their customers with more accessible payment options. Car owners in the US typically spend ~$800 annually on vehicle maintenance. Affirm's share price has already seen a 40% increase over the past quarter, which shows strong investor confidence. An entrepreneur launching her new brand on the company's platform, looking confident and joyful. The sentiment is further fueled by Affirm's return to profitability in its latest earnings report and its expanding partnerships with major companies like Costco and Williams-Sonoma in Canadian markets. Over the past 3 years, Affirm's total shareholder return soared by 248.32%, outperforming the broader US Market and the Diversified Financial industry over the last year. Affirm Holdings Inc. (NASDAQ:AFRM) operates a payment network in the US, Canada, and internationally. Shopmonkey is a cloud-based auto shop management platform. While we acknowledge the potential of AFRM as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data